Adriamycin 50mg Injection

Name: Adriamycin 50mg Injection
Brand: SIDMEX INOVIA PRIVATE LIMITED
Price: 889.0 INR
Availability: InStock

Price 889.0 INR/ Pack

Get a Price/Quote

MOQ : 50 Packs

Adriamycin 50mg Injection Specification

Drug Type
Injection

Physical Form
Liquid

Recommended For
Doctor

Dosage Guidelines
As per Instructions

Suitable For
Adults

Storage Instructions
Cool & Dry Place

Adriamycin 50mg Injection Trade Information

Minimum Order Quantity
50 Packs

Payment Terms
Cash in Advance (CID), Telegraphic Transfer (T/T), Cash Advance (CA)

Supply Ability
3000 Packs Per Week

Delivery Time
6 Days

Sample Available
No

Sample Policy
If order is confirmed we will reimburse the sample cost

Main Export Market(s)
Asia, North America, Western Europe, Australia, Central America, South America, Eastern Europe, Middle East, Africa

Main Domestic Market
All India

About Adriamycin 50mg Injection

1. Technical Specifications

Attribute	Details
Brand Name	Adriamycin Injection
Generic Name	Doxorubicin Hydrochloride
Strength	50 mg per vial
Dosage Form	Lyophilized Powder / Solution for IV Injection
Packaging Size	1 vial per pack
Packaging Type	Sterile glass vial
Medicine Type	Anticancer Anthracycline Chemotherapy
Manufacturer	Commonly marketed by Pfizer, Johnson & Johnson (Janssen), and other oncology divisions (manufacturers may vary by region)
Distributed By	Authorized oncology distributors / hospital pharmacies

2. Product Description

Adriamycin contains Doxorubicin Hydrochloride, a widely used anthracycline antibiotic chemotherapy drug.
It works by intercalating DNA strands, inhibiting topoisomerase II, and generating free radicals, leading to cancer cell death.

It is a cornerstone in chemotherapy regimens for hematological malignancies and solid tumors.

3. Product Highlights

Attribute	Details
Therapeutic Category	Anticancer Anthracycline Cytotoxic Agent
Application Area	Breast Cancer, Leukemias, Lymphomas, Ovarian Cancer, Bladder Cancer, Lung Cancer, Soft Tissue Sarcoma
Mechanism of Action	DNA intercalation + topoisomerase II inhibition blocks DNA replication apoptosis
Administration	Intravenous injection/infusion, administered by oncologists only
Storage Conditions	Store at 28 C (refrigerated); protect from light; do not freeze

4. Therapeutic Uses

Breast Cancer (early & metastatic)
Acute Leukemias (AML, ALL)
Lymphomas (Hodgkins & Non-Hodgkins)
Soft Tissue Sarcomas
Bladder, Ovarian, Lung & Thyroid Cancers
Used in many combination chemotherapy regimens (e.g., CHOP, ABVD)

5. Side Effects

Common:

Nausea, vomiting
Hair loss (alopecia)
Low blood counts (myelosuppression)
Fatigue, weakness
Mouth sores (mucositis)

Serious / Severe:

Cardiotoxicity (congestive heart failure, cardiomyopathy dose-dependent & cumulative)
Severe myelosuppression infections, bleeding risk
Secondary leukemia (rare, long-term risk)
Infusion site reactions (vesicant can cause tissue necrosis if extravasated)
Liver toxicity

6. Precautions

Cardiac Monitoring: Echocardiogram/MUGA scan recommended before and during therapy.
Lifetime Dose Limit: Cumulative dose of doxorubicin should not exceed 450550 mg/m to avoid irreversible heart damage.
Myelosuppression: CBC monitoring before each cycle.
Liver Function: Dose adjustment needed in hepatic impairment.
Pregnancy/Breastfeeding: Contraindicated (teratogenic & excreted in breast milk).
Extravasation Risk: Administer through central line whenever possible.

Powerful Oncology Solution

Adriamycin 50mg Injection is widely recognized for its efficacy in cancer management. Its use is reserved for adults and administered strictly under a doctors supervision in clinical settings. As a critical part of chemotherapy regimens, Adriamycin has become a cornerstone for healthcare providers and distributors alike.

Proper Storage Ensures Potency

To preserve the quality and effectiveness of Adriamycin 50mg Injection, it must be stored in a cool, dry area away from direct sunlight. Proper storage conditions prevent degradation of the liquid formulation, ensuring reliable performance for suppliers and end-users.

FAQs of Adriamycin 50mg Injection:

Q: How should Adriamycin 50mg Injection be administered?

A: Adriamycin 50mg Injection must be administered by a qualified healthcare professional, usually via intravenous injection or infusion, in a hospital setting following a doctors prescribed dosage guidelines.

Q: What precautions should be taken before using Adriamycin 50mg Injection?

A: This medication is suitable only for adults and must be given under strict medical supervision. Inform your doctor of any pre-existing conditions, allergies, or concurrent medications to prevent adverse reactions.

Q: When should Adriamycin 50mg Injection be used during treatment?

A: Adriamycin is typically used as part of a chemotherapy regimen, as determined by an oncologist. The timing and frequency of administration depend on the type of cancer and the patients response to treatment.

Q: Where should Adriamycin 50mg Injection be stored for optimal effectiveness?

A: Store the injection in a cool and dry place away from direct heat or sunlight to maintain its stability and therapeutic efficacy.

Q: What is the process for supplying Adriamycin 50mg Injection in India?

A: Distribution is managed by authorized entities such as distributors, exporters, suppliers, traders, and wholesalers, ensuring compliance with national pharmaceutical regulations and safety standards.

Q: What are the main benefits of using Adriamycin 50mg Injection?

A: Adriamycin effectively targets and destroys cancer cells, making it a valuable component in chemotherapy protocols for various cancers when used properly as directed by a medical professional.

Tell us about your requirement